Loading provider…
Loading provider…
Urology Physician in Norfolk, VA
NPI: 1295058394Primary Practice Location
SENTARA NORFOLK GENERAL HOSPITAL
600 Gresham Dr, Norfolk, VA
Primary Employer
Urology of Virginia, PLLC
urologyofva.net
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
VA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 504 | 771 |
| 2 | 81003Automated urinalysis test | 483 | 980 |
| 3 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 243 | 389 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 208 | 239 |
| 5 | 84153PSA (prostate specific antigen) measurement | 200 | 320 |
Authors: Vikram Narayan, Thomas Guzzo, Badrinath Konety, Sam Chang, Anne Schuckman, Michael Cookson, Michael Odonnell, Gordon Brown, Michael Poch, Brian Lane, Seth Lerner, Tracy Downs, Yair Lotan, Joseph Mashni, Mehrdad Alemozaffar, Joseph Busby, Daniel Canter, Adam Luchey, Colin Dinney, Ashish Kamat, Paul Crispen, Lawrence Karsh, Stephen Boorjian, Leonard Gomella, Gennady Bratslavsky, Alexander Sankin
Journal: J Urol
Publication Date: 2024-05-05
Authors: Christopher Stewart, Raoul Concepcion, Michael Williams, Lawrence Karsh, Christopher Pieczonka
Journal: Prostate
Publication Date: 2020-08-11
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
Authors: Timothy Bradford, Barry Shepard, Andrew Trainer, Ellen Wallace, Richard David, Karl Westenfelder
Publication Date: 2018-06-25
Lead Sponsor: Dendreon
Intervention / Treatment: BIOLOGICAL: Sipuleucel-T
Lead Sponsor: Dendreon
Lead Sponsor: Loxo Oncology, Inc.
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Venetoclax, DRUG: Rituximab, DRUG: Pirtobrutinib